Mona-Elisabeth Revheim
Papers
1
Total Citations
4
H-Index
1
About
Dr. Mona-Elisabeth Revheim is a leading researcher in molecular imaging and nuclear medicine, with a primary focus on prostate cancer diagnostics. Her work bridges the gap between positron emission tomography (PET) and magnetic resonance imaging (MRI), particularly through the use of novel radiotracers. In her highly cited 2018 study comparing dynamic ¹⁸F-fluciclovine PET with dynamic contrast-enhanced MRI for primary prostate carcinomas, Dr. Revheim demonstrated how multimodal imaging can provide complementary information about tumor perfusion and metabolism. This work, which has garnered over 4 citations, is foundational for integrating PET and MRI in clinical prostate cancer assessment. Her research advances the understanding of how radioactive tracers and contrast agents behave in the initial perfusion phase, offering critical insights for more accurate tumor characterization. Dr. Revheim’s contributions are shaping the future of precision oncology, helping to refine non-invasive diagnostic strategies that improve patient outcomes. Her dedication to translational imaging research continues to influence both clinical practice and the development of next-generation imaging protocols.
Research Focus
Key Achievements
Top Papers
- 1